SCHEMBL3666166

SCHEMBL3666166

CC(C)(Cl)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2227105 0.96
SCHEMBL10933443 0.82
SCHEMBL5181449 0.75
SCHEMBL2570303 0.72
SCHEMBL304888 0.70
SCHEMBL7290 0.70
Hydrochloric Acid SCHEMBL853938 0.70
SCHEMBL4666457 0.67
Iodide SCHEMBL1726656 0.67
Fluoride SCHEMBL22032641 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580399-B2 Geranyl flavonoid derivative with improved water solubility, a method for preparing the same, and a method for treating cancer using the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-02-28 US claimed
US-20160060239-A1 GERANYL FLAVONOID DERIVATIVE WITH IMPROVED WATER SOLUBILITY, A METHOD FOR PREPARING THE SAME, AND A METHOD FOR TREATING CANCER USING THE SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2016-03-03 US claimed
US-9580399-B2 Geranyl flavonoid derivative with improved water solubility, a method for preparing the same, and a method for treating cancer using the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-02-28 US disclosed
US-20160060239-A1 GERANYL FLAVONOID DERIVATIVE WITH IMPROVED WATER SOLUBILITY, A METHOD FOR PREPARING THE SAME, AND A METHOD FOR TREATING CANCER USING THE SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2016-03-03 US disclosed
EP-2242742-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2015-12-02 EP disclosed
US-20150239849-A1 INHIBITORS OF BETA-SECRETASE DOW AGROSCIENCES LLC 2015-08-27 US disclosed
US-20150239849-A1 INHIBITORS OF BETA-SECRETASE DOW AGROSCIENCES LLC 2015-08-27 US disclosed
US-9018391-B2 Inhibitors of beta-secretase BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-04-28 US disclosed
WO-2014035860-A1 INHIBITORS OF BETA-SECRETASE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-06 WO disclosed
US-20140057927-A1 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. 2014-02-27 US disclosed
US-8343966-B2 Organic compounds NOVARTIS AG (CH) 2013-01-01 US disclosed
US-20040192693-A1 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-09-30 US disclosed
US-5196531-A Poly(N-cyclic iminoether), process for production thereof, thermosetting composition containing it and thermoset resin TEIJIN LIMITED (JP) 1993-03-23 US disclosed
EP-0487423-A1 Benzoselenazolinone derivatives, their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1992-05-27 EP disclosed
US-4485042-A COLORFASTNESS CASSELLA AKTIENGESELLSCHAFT (DE) 1984-11-27 US disclosed
US-4474988-A ETHERIFICATION FROM CORRESPONDING ALCOHOL, ACID CATALYSTS UNION CARBIDE CORPORATION (US) 1984-10-02 US disclosed
EP-0115071-A1 Process for the production of bis-(N,N-dialkylamino)alkyl ethers and the use of said ethers UNION CARBIDE CORPORATION (US) 1984-08-08 EP disclosed
US-4342763-A USEFUL AS ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS AND ANTITUSSIVE AGENTS PROVESAN S.A. (CH) 1982-08-03 US disclosed
US-4130650-A 1-METHYL- OR DIMETHYL-AMINOETHOXY, 2-PYRIDYLVINYL-BENZENE BOEHRINGER INGELHEIM GMBH (DE) 1978-12-19 US disclosed
US-3933793-A BACTERICIDES, VIRICIDES RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1976-01-20 US disclosed